Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clodronate 200 mg vs 100 mg IM in Postmenopausal Osteoporosis
NCT01348243Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Oct 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clodronate in postmenopausal osteoporosis, sponsored by Chiesi Farmaceutici S.p.A.. Started Oct 2011; status: completed.
02
Drugs
clodronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT01348243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01348243.